Rx Roundup: Quiz of the Week — June 28, 2024

Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.

Good Neighbor Pharmacy customers from rural, suburban, and city areas reflect on the past year and discuss the future of independent pharmacy.

Investigators said there is an imperative to optimize medication utilization and explore the consequences of medication burden on treatment outcomes in patients with long COVID.

Our latest podcast episode discusses how pharmacies can tap technology to boost vaccination programs for COVID-19 vaccines and others.

A study found that a continuous glucose monitor workflow led by a pharmacist led to reduced HbA1c levels.

The data from PURPOSE 2 will be published in The New England Journal of Medicine.